Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$207.78

-0.77 (-0.37%)

, AMAT

Applied Materials

$56.90

-0.23 (-0.40%)

13:09
11/14/19
11/14
13:09
11/14/19
13:09

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include NVIDIA (NVDA), consensus $1.57... Applied Materials (AMAT), consensus 76c... Wheaton Precious Metals (WPM), consensus 16c... Dolby Laboratories (DLB), consensus 48c... Helmerich & Payne (HP), consensus 23c.

NVDA

Nvidia

$207.78

-0.77 (-0.37%)

AMAT

Applied Materials

$56.90

-0.23 (-0.40%)

WPM

Wheaton Precious Metals

$26.64

0.05 (0.19%)

DLB

Dolby

$65.71

0.01 (0.02%)

HP

Helmerich & Payne

$39.57

0.31 (0.79%)

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 06

    Jan

NVDA Nvidia
$207.78

-0.77 (-0.37%)

11/12/19
SUSQ
11/12/19
NO CHANGE
Target $240
SUSQ
Positive
Nvidia price target raised to $240 from $190 at Susquehanna
Susquehanna analyst Christopher Rolland raised his price target for Nvidia (NVDA) to $240 from $190 ahead of the company's Q3 results on November 14. While difficult to make a clear call on the quarter, this is the first time in many quarters that expectations are generally in-check with typical seasonality, Rolland tells investors in a pre-research note. He points out that Nvidia in the quarter refreshed its high-end RTX cards to combat the 7nm graphics processing unit launch from AMD (AMD). While AMD was able to gain modest share in aftermarket graphics cards during the quarter and is now rumored to be launching a lower-priced Navi GPU to compete in the midrange, the analyst believes Nvidia will take back most lost share on the release of 7nm next year. With the company facing "the most reasonable Street expectations in quite some time," Rolland reiterates a Positive rating on Nvidia.
11/12/19
OPCO
11/12/19
NO CHANGE
Target $250
OPCO
Outperform
Nvidia price target raised to $250 from $190 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Nvidia to $250 from $190 ahead of its quarterly earnings, saying he expects a beat and raise set up for Q3. In a research note to investors, Schafer, who maintains an Outperform rating, says he sees upside led by continued post-crypto rebound in core gaming as well as improved hyperscaler spend on DC/Cloud and adds that he remains a buyer of Nvidia, as the company appears positioned to capitalize on long-term secular trends in DC, high performance gaming, and autonomous vehicles.
11/11/19
DBAB
11/11/19
NO CHANGE
Target $190
DBAB
Hold
Nvidia price target raised to $190 from $160 at Deutsche Bank
Deutsche Bank analyst Ross Seymore raised his price target for Nvidia to $190 from $160 ahead of the company's Q3 results and keeps a Hold rating on the shares. With the stock up 30% since the company's last earnings report, investors are expecting a "solid beat/raise heading into earnings," Seymore tells investors in a research note. He sees potential for "modest" upside relative to expectations but believes "much of this goodness is already reflected in the shares."
11/14/19
BMOC
11/14/19
NO CHANGE
Target $200
BMOC
Market Perform
Nvidia price target raised to $200 from $145 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Nvidia to $200 ahead of its Q3 earnings later today, saying the setup going into the print is "relatively positive" with a "cleaned up" supply chain in the Gaming segment and recovery among other chip companies supporting expectations for the Data Center segment. The analyst adds that he is "playing catch-up" with the target price but also maintains his Market Perform rating, noting that the stock is reasonably valued at current levels.
AMAT Applied Materials
$56.90

-0.23 (-0.40%)

11/12/19
WELS
11/12/19
NO CHANGE
Target $62
WELS
Outperform
Applied Materials price target raised to $62 from $58 at Wells Fargo
Wells Fargo analyst Joe Quatrochi raised his price target for Applied Materials to $62 from $68 ahead of the company's Q4 earnings report, saying shares already largely reflect an expectation of continued foundry/logic spending strength in Q4 and potential upside to the current Q1 consensus revenue estimate. Quatrochi tells investors in a research note that he thinks the company's commentary will continue to support the current consensus estimate calling for 2020 total revenue growth of ~11% y/y. The analyst reiterates an Outperform rating on the shares.
11/12/19
COWN
11/12/19
NO CHANGE
Target $65
COWN
Outperform
Applied Materials price target raised to $65 from $55 at Cowen
Cowen analyst Krish Sankar raised his price target on Applied Materials to $65 from $55 ahead of earnings on Thursday. The analyst noted the stock's upward move since its last earnings report citing the strength in foundry/logic capital spending, along with positive results and commentary from customers and peers. He said he remains bullish on the name and called its his top semi-cap pick. Sankar reiterated his Outperform rating on Applied Materials shares.
10/29/19
DZBN
10/29/19
DOWNGRADE
Target $46
DZBN
Sell
Applied Materials downgraded to Sell from Hold at DZ Bank
DZ Bank analyst Ingo Wermann downgraded Applied Materials to Sell from Hold with a $46 price target.
11/12/19
STFL
11/12/19
NO CHANGE
Target $67
STFL
Buy
Applied Materials price target raised to $67 from $57 at Stifel
Stifel analyst Patrick Ho raised his price target for Applied Materials to $67 from $57 and maintains a Buy rating on the shares ahead of the company's Q4 results. Large-cap names, like Applied Materials, deserve higher multiples, particularly when compared to other industrial names, Ho tells investors in a research note. The analyst expects a "more optimistic" tone on the company's earnings call, that sets up 2020 for an above-average growth year. Applied Materials remains Ho's top large cap name in his coverage universe.
WPM Wheaton Precious Metals
$26.64

0.05 (0.19%)

10/15/19
LEHM
10/15/19
DOWNGRADE
LEHM
Equal Weight
Wheaton Precious Metals downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Matthew Murphy downgraded Wheaton Precious Metals to Equal Weight from Overweight with a price target of C$37.05.
07/23/19
MITR
07/23/19
DOWNGRADE
MITR
Hold
Wheaton Precious Metals downgraded to Hold from Buy at GMP Securities
07/23/19
07/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Devon Energy (DVN) reinstated with a Sell from Neutral at Goldman Sachs with analyst Brian Singer saying the stock's year-to-date outperformance relative to peers is "overdone" as the remaining sum-of-the-parts valuation for the shares is "too rich" following the sale of its Canadian business. 2. Sprouts Farmers Market (SFM) downgraded to Perform from Outperform at Oppenheimer with analyst Rupesh Parikh citing his assessment of potentially more muted profit growth going forward coupled with increasing uncertainty on the management and competitive fronts. 3. Viveve (VIVE) double downgraded to Underperform from Buy at Mizuho, downgraded to Hold from Buy at Stifel and to Market Perform from Outperform at Raymond James. 4. Wheaton Precious Metals (WPM) downgraded to Hold from Buy at GMP Securities. 5. Cadence Bancorp (CADE) downgraded to Neutral from Buy at Goldman Sachs and to Market Perform from Outperform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/15/19
LEHM
10/15/19
DOWNGRADE
LEHM
Equal Weight
Barclays downgrades Kinross Gold, Wheaton Precious Metals on valuation
Barclays analyst Matthew Murphy downgraded both Kinross Gold (KGC) and Wheaton Precious Metals (WPM) to Equal Weight from Overweight ahead of the Q3 earnings season. The analyst, who admits fundamentals for the precious metal miners continue to improve, sees valuations in the North America Metals and Mining space as "quite full." He cites valuation for both downgrades.
DLB Dolby
$65.71

0.01 (0.02%)

08/02/19
WBLR
08/02/19
NO CHANGE
WBLR
Outperform
Dolby core licensing business remains intact, says William Blair
Shares of Dolby Laboratories are trading down after the company lowered full-year revenue guidance and announced an unexpected restructuring charge this quarter, William Blair analyst Ralph Schackart tells investors in a research note. However, Dolby posted a 3% beat on licensing revenues for the second quarter in a row, adds the analyst. He remains bullish on Dolby and believes its core licensing business is intact. Schackart keeps an Outperform rating on the shares.
08/02/19
RILY
08/02/19
UPGRADE
RILY
Buy
Dolby upgraded to Buy from Neutral at B. Riley FBR
05/31/19
DOTC
05/31/19
NO CHANGE
DOTC
Buy
Recent developments point to continued Dolby ecosystem expansion, says Dougherty
Dougherty analyst Steven Frankel noted that Vizio recently unveiled its Holiday 2019 TV line-up, "with Dolby Vision featured from top to bottom," that the recently released One Plus 7 smartphone includes Atmos, and that Dell has recently upgraded its Dolby Vision enabled XP 13 notebook. Additionally, Apple's (AAPL) iTunes continues to extend its catalog of Vision and Atmos content, according to Frankel, who sees the company's ability to drive a "virtuous circle of content and devices" embedded with its technologies as core to Dolby's (DLB) success. He keeps a Buy rating on Dolby shares.
08/02/19
RILY
08/02/19
UPGRADE
Target $73
RILY
Buy
B. Riley FBR upgrades Dolby amid today's selloff, sees 22% upside
B. Riley FBR analyst Eric Wold upgraded Dolby Laboratories to Buy from Neutral and raised his price target for the shares to $73 from $67. The analyst sees 22% upside potential given today's post-earnings selloff. The stock in late morning trading is down 12%, or $8.34, to $59.74. Wold is "increasingly optimistic" on Dolby's improving penetration rates for its audio/visual technologies and highlights its accelerated share repurchases.
HP Helmerich & Payne
$39.57

0.31 (0.79%)

10/08/19
BOFA
10/08/19
DOWNGRADE
BOFA
BofA sees more weakness ahead for U.S. land drillers, downgrades four stocks
As previously reported, BofA Merrill Lynch analyst Chase Mulvehill downgraded Helmerich & Payne (HP) and Patterson-UTI (PTEN), each to Neutral from Buy, and downgraded Nine Energy Services (NINE) and FTS International (FTSI), each to Underperform from Neutral. Mulvehill said capital discipline and service efficiency gains from U.S. E&P comapnies is leading to intensifying weakness across the Oil Field Services sector, driving activity that has been even worse than his already more cautious view. He also sees it as increasingly likely that 2020 will be another year of spending contraction for U.S. explorers and producers. For the two stocks he cut to Underperform, Mulvehill additionally cited the companies' levered balance sheets.
10/08/19
10/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL), Carbonite (CARB), and Check Point (CHKP) downgraded to Hold from Buy at Jefferies. 2. TerraForm Power (TERP) downgraded to Equal Weight from Overweight at Barclays. 3. Puma Biotechnology (PBYI) downgraded to Sell from Neutral at Goldman Sachs while Nektar Therapeutics (NKTR) was double downgraded to Sell from Buy. 4. Qiagen (QGEN) downgraded to Underweight from Neutral at JPMorgan and to Equal Weight from Overweight at Barclays. 5. Helmerich & Payne (HP) and Patterson-UTI (PTEN) downgraded to Neutral from Buy at BofA/Merrill. Nine Energy Services (NINE) and FTS International (FTSI) downgraded to Underperform from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/08/19
BOFA
10/08/19
DOWNGRADE
BOFA
Neutral
Helmerich & Payne downgraded to Neutral from Buy at BofA/Merrill
09/30/19
SBSH
09/30/19
DOWNGRADE
Target $43
SBSH
Neutral
Helmerich & Payne downgraded to Neutral from Buy at Citi
Citi analyst Scott Gruber downgraded Helmerich & Payne to Neutral from Buy and lowered his price target for the shares to $43 from $50. The analyst recently cut his 2020 U.S. rig count forecast, which now calls for a 5% year-over-year decline next year. Falling utilization across both super spec and standard rig classes likely weigh on pricing, Gruber tells investors in a research note. The analyst adds that despite the recent pullback in shares of land drillers, his estimates are now ~30% below consensus for 2020.

TODAY'S FREE FLY STORIES

SFET

Safe-T

$4.85

-0.31 (-6.01%)

15:39
12/05/19
12/05
15:39
12/05/19
15:39
Syndicate
Breaking Syndicate news story on Safe-T »

Safe-T files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFET

Safe-T

$4.85

-0.31 (-6.01%)

15:37
12/05/19
12/05
15:37
12/05/19
15:37
Syndicate
Breaking Syndicate news story on Safe-T »

Safe-T files $20M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:34
12/05/19
12/05
15:34
12/05/19
15:34
Conference/Events
UBS leisure/gaming analyst to hold an analyst/industry conference call. »

Leisure, Gaming &…

CRWD

Crowdstrike

$52.76

-2.28 (-4.14%)

15:34
12/05/19
12/05
15:34
12/05/19
15:34
Options
CrowdStrike Holdings options imply 15.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

ICON

Iconix Brand

$1.09

-0.05 (-4.39%)

15:33
12/05/19
12/05
15:33
12/05/19
15:33
Hot Stocks
Iconix Brand to pay civil penalty of $5.5M to settle outstanding SEC claims »

Iconix Brand announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$91.59

0.035 (0.04%)

15:32
12/05/19
12/05
15:32
12/05/19
15:32
Hot Stocks
FDA approves first generics of Gilenya »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 09

    Dec

AMZN

Amazon.com

$1,744.04

-17.16 (-0.97%)

15:31
12/05/19
12/05
15:31
12/05/19
15:31
Hot Stocks
Amazon Web Services, NFL partner over player health, safety »

Amazon Web Services and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.06

-2.83 (-0.81%)

, EADSY

Airbus

$0.00

(0.00%)

15:29
12/05/19
12/05
15:29
12/05/19
15:29
Periodicals
Airbus looks to beat Boeing in order race, Reuters reports »

Airbus (EADSY) booked…

BA

Boeing

$346.06

-2.83 (-0.81%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$61.00

-88.22 (-59.12%)

15:26
12/05/19
12/05
15:26
12/05/19
15:26
Downgrade
Sage Therapeutics rating change  »

RBC downgrades Sage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.87

-88.35 (-59.21%)

15:20
12/05/19
12/05
15:20
12/05/19
15:20
Downgrade
Sage Therapeutics rating change  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.61

-0.34 (-0.49%)

15:19
12/05/19
12/05
15:19
12/05/19
15:19
Options
Zoom Video Communications options imply 13.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/05/19
12/05
15:17
12/05/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/05/19
12/05
15:16
12/05/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$311.93

0.46 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

15:11
12/05/19
12/05
15:11
12/05/19
15:11
Periodicals
China reassures on trade talks, but sides 'at odds' on some issues, WSJ says »

China's Commerce…

SPY

SPDR S&P 500 ETF Trust

$311.93

0.46 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASX

ASE Technology

$5.02

0.12 (2.45%)

15:04
12/05/19
12/05
15:04
12/05/19
15:04
Upgrade
ASE Technology rating change  »

ASE Technology upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.54

-2.82 (-1.18%)

15:04
12/05/19
12/05
15:04
12/05/19
15:04
Options
Ulta Beauty options imply 12.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

WCN

Waste Connections

$90.62

0.39 (0.43%)

15:03
12/05/19
12/05
15:03
12/05/19
15:03
Conference/Events
Waste Connections participates in a conference call with UBS »

Environmental Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 12

    Dec

15:00
12/05/19
12/05
15:00
12/05/19
15:00
Conference/Events
UBS alternative energy windham to hold an analyst/industry conference call »

Alternative Energy &…

14:56
12/05/19
12/05
14:56
12/05/19
14:56
Conference/Events
UBS alternative energy windham to hold an analyst/industry conference call »

Alternative Energy &…

PYX

Pyxus

$7.58

-0.1 (-1.30%)

14:49
12/05/19
12/05
14:49
12/05/19
14:49
Hot Stocks
Pyxus' Figr Brands enters Ontario legal cannabis market »

Pyxus International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

$9.93

0.065 (0.66%)

14:49
12/05/19
12/05
14:49
12/05/19
14:49
Options
Cloudera options imply 20.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

CC

Chemours

$15.04

-0.375 (-2.43%)

14:48
12/05/19
12/05
14:48
12/05/19
14:48
Periodicals
Chemours tells Bloomberg final agreement on PFAS designation not yet reached »

A Chemours spokesperson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

QCOM

Qualcomm

$82.18

0.1 (0.12%)

14:48
12/05/19
12/05
14:48
12/05/19
14:48
Hot Stocks
Qualcomm launches its XR2 platform for 'a new era of AR, VR and MR experiences' »

Qualcomm announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

TSM

TSMC

$54.38

1.21 (2.28%)

14:45
12/05/19
12/05
14:45
12/05/19
14:45
Options
Taiwan Semi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$199.02

0.32 (0.16%)

14:39
12/05/19
12/05
14:39
12/05/19
14:39
Periodicals
Facebook sues Hong Kong's ILikeAd over claims of ad fraud, Reuters reports »

Facebook is suing a Hong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.